BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHNGU
3376
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
| $17.2M | ﹤0.01% |
225,614
-29,252
| -11% | -$2.25M |
|
3377
Peoples Financial Services
PFIS
$720M
| $17.1M | ﹤0.01% |
402,013
-30,179
| -7% | -$1.3M |
|
3378
CorMedix
CRMD
$588M
| $17.1M | ﹤0.01% |
2,493,014
+239,720
| +11% | +$1.91M |
|
3379
Main Street Capital
MAIN
$5.28B
| $17.1M | ﹤0.01% |
416,141
+38,344
| +10% | +$1.59M |
|
3380
XP
XP
$8.84B
| $17.1M | ﹤0.01% |
392,436
+292,832
| +294% | +$12.1M |
|
3381
Agnico Eagle Mines
AEM
$76.9B
| $17M | ﹤0.01% |
281,431
-16,494
| -6% | -$1.1M |
|
|
ESTE
3382
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $17M | ﹤0.01% |
1,534,750
+38,987
| +3% | +$354K |
|
3383
Oramed Pharmaceuticals
ORMP
$177M
| $17M | ﹤0.01% |
1,269,530
+1,190,970
| +1,516% | +$13.6M |
|
|
NOTV
3384
DELISTED
Inotiv
NOTV
| $17M | ﹤0.01% |
635,747
+602,245
| +1,798% | +$15.1M |
|
3385
Superior Group of Companies
SGC
$212M
| $16.9M | ﹤0.01% |
708,314
-5,449
| -0.8% | -$137K |
|
|
CSPR
3386
DELISTED
Casper Sleep Inc.
CSPR
| $16.9M | ﹤0.01% |
2,048,493
-105,812
| -5% | -$923K |
|
3387
UWM Holdings
UWMC
$658M
| $16.8M | ﹤0.01% |
1,991,650
+653,934
| +49% | +$5.47M |
|
|
OYST
3388
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $16.8M | ﹤0.01% |
978,668
+240,461
| +33% | +$4.57M |
|
3389
First Internet Bancorp
INBK
$256M
| $16.8M | ﹤0.01% |
541,194
-132,792
| -20% | -$4.51M |
|
3390
Atlanticus Holdings
ATLC
$1.67B
| $16.7M | ﹤0.01% |
421,681
-193,830
| -31% | -$6.79M |
|
|
STR
3391
DELISTED
Sitio Royalties
STR
| $16.7M | ﹤0.01% |
823,134
-48,700
| -6% | -$935K |
|
3392
Rush Enterprises Class B
RUSHB
$6.26B
| $16.7M | ﹤0.01% |
657,649
-22,412
| -3% | -$644K |
|
3393
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$720M
| $16.7M | ﹤0.01% |
382,973
-290,974
| -43% | -$12.7M |
|
|
JNCE
3394
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $16.7M | ﹤0.01% |
2,457,099
+617,800
| +34% | +$5.13M |
|
3395
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $16.7M | ﹤0.01% |
2,687,304
+171,807
| +7% | +$1.02M |
|
|
AMAM
3396
DELISTED
Ambrx Biopharma Inc
AMAM
| $16.7M | ﹤0.01% |
+850,676
| New | +$14.5M |
|
3397
Fortress Biotech
FBIO
$89.7M
| $16.7M | ﹤0.01% |
311,146
-12,612
| -4% | -$761K |
|
3398
eGain
EGAN
$198M
| $16.5M | ﹤0.01% |
1,439,299
-204,419
| -12% | -$2.09M |
|
3399
Mustang Bio
MBIO
$4.45M
| $16.4M | ﹤0.01% |
6,584
+1,271
| +24% | +$3.12M |
|
|
CDAK
3400
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $16.4M | ﹤0.01% |
884,166
+445,730
| +102% | +$8.56M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.